Cite
Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian-Indian population but may not be a risk for stroke.
MLA
Biswas, Arijit, et al. “Thrombin Activatable Fibrinolysis Inhibitor Gene Polymorphisms Are Associated with Antigenic Levels in the Asian-Indian Population but May Not Be a Risk for Stroke.” British Journal of Haematology, vol. 143, no. 4, Nov. 2008, pp. 581–88. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2008.07384.x.
APA
Biswas, A., Tiwari, A. K., Ranjan, R., Meena, A., Akhter, M. S., Yadav, B. K., Behari, M., & Saxena, R. (2008). Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian-Indian population but may not be a risk for stroke. British Journal of Haematology, 143(4), 581–588. https://doi.org/10.1111/j.1365-2141.2008.07384.x
Chicago
Biswas, Arijit, Arun K. Tiwari, Ravi Ranjan, Arvind Meena, Mohammad S. Akhter, Birendra K. Yadav, Madhuri Behari, and Renu Saxena. 2008. “Thrombin Activatable Fibrinolysis Inhibitor Gene Polymorphisms Are Associated with Antigenic Levels in the Asian-Indian Population but May Not Be a Risk for Stroke.” British Journal of Haematology 143 (4): 581–88. doi:10.1111/j.1365-2141.2008.07384.x.